drugset / Trial / NCT02845778
Pharmacokinetics of Melatonin Niosomes Oral Gel in Healthy Volunteers
RandomizedCrossoverTriple-blind
Summary
Melatonin is an endogenous hormone. It is able to promote nighttime sleeping and could induce sleep at daytime in adult and children with the nonpainful diagnostic procedure. However, previous formulation had problems of unstability of product and low oral bioavailability. Melatonin niosomes oral gels are formulated in order to overcome the problem of drug absorption and stability. This study is a randomized, double-blind, three phase crossover design in 15 male volunteers. Melatonin niosomes oral gel will be applied at doses 2.5, 5, and 10 mg with 7 days washout for each period. The pharmacokinetics data, sleep induction effect, and adverse event will be determined.
Timeline
- Start
- 2016-05
- Primary completion
- 2016-08
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | 2.5 mg | Oral |
| Subject | Melatonin | Small molecule | 5 mg | Oral |
| Subject | Melatonin | Small molecule | 10 mg | Oral |
Indications
No indication recorded.